Regeneron Pharmaceuticals
REGN
#226
Rank
A$128.74 B
Marketcap
$1,172
Share price
2.09%
Change (1 day)
-7.76%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): A$7.35 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$13.84 Billion. In 2023 the company made an earning of A$6.64 Billion a decrease over its 2022 earnings that were of A$7.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$7.35 B10.56%
2023 A$6.64 B-13.57%
2022 A$7.69 B-47.9%
2021 A$14.76 B144.75%
2020 A$6.03 B56.86%
2019 A$3.84 B-4.87%
2018 A$4.04 B22.86%
2017 A$3.29 B56.3%
2016 A$2.10 B8.55%
2015 A$1.93 B54.53%
2014 A$1.25 B11.14%
2013 A$1.12 B72.13%
2012 A$0.65 B-285.93%
2011 -A$0.36 Billion121.73%
2010 -A$0.16 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.14 Billion-25.02%
2007 -A$0.19 Billion6.32%
2006 -A$0.18 Billion-186.52%
2005 A$0.19 B2103.7%
2004 A$8.93 M-105.66%
2003 -A$0.16 Billion-18.18%
2002 -A$0.2 Billion42.33%
2001 -A$0.14 Billion129.35%
2000 -A$59.15 Million51.87%
1999 -A$38.95 Million92.19%
1998 -A$20.27 Million66.23%
1997 -A$12.2 Million-55.49%
1996 -A$27.39 Million103.53%
1995 -A$13.46 Million-70.89%
1994 -A$46.23 Million-26.08%
1993 -A$62.54 Million114.67%
1992 -A$29.14 Million196.77%
1991 -A$9.82 Million87.88%
1990 -A$5.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.40 B-5.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.3 Billion-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.01 B-61.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.12 B 270.17%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.15 B 156.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$11.72 B 49.07%๐Ÿ‡ซ๐Ÿ‡ท France